Nicorandil in angina: a favourable economic impact

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.507, 2006-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicorandil beneficial in chronic stable angina

Inpharma, Vol. 1, Iss. 1334, 2002-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Nicorandil reduces risk of major coronary events in patients with angina

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Nicorandil: A Review of its Use in the Management of Stable Angina Pectoris, Including High-Risk Patients

By Simpson Dene Wellington Keri

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1941-1955

Adis International

Access to resources Recommend Favorite

Economic benefits with enoxaparin sodium in unstable angina

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Ramipril: clinical, economic advantages in diabetes, stable angina

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 413, 2003-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite